News Focus
News Focus
icon url

DewDiligence

12/10/10 3:47 PM

#110663 RE: pollyvonwog #110661

So why go at it again? Seems a bit silly.

The new CP will presumably be rejected; however, Teva has a lot to gain and nothing to lose by trying again.